ENO1 and ovarian cancer: In the current study, we surprisingly demonstrate that HPD works as an RBP to promote ovarian cancer glycolysis flux by increasing global mRNA translation, including glycolytic metabolic enzymes TPI and ENO1, thereby promoting the tumorigenesis of ovarian cancer.